Content » Vol 100, May

Investigative Report

Patient-Oriented Eczema Measure score: A Useful Tool for Web-Based Surveys in Patients with Atopic Dermatitis

Makiko Kido-Nakahara, Takeshi Nakahara, Yumi Yasukochi, Dugarmaa Ulzii, Masutaka Furue
DOI: 10.2340/00015555-3530

Abstract

The Patient-Oriented Eczema Measure (POEM, 0–28 points) is a self-assessed, repeatable measurement tool for measuring atopic dermatitis (AD) severity. How­ever, whether POEM score is influenced by allergic comorbidities and whether POEM’s severity banding is applicable in web-based surveys for AD remain unclear. A web-based questionnaire survey was conducted in 329 patients with AD. POEM, self-reported severity of AD, and comorbidity of allergic diseases including asthma, pollen rhinitis, allergic conjunctivitis, and food allergy were assessed. POEM scores were not affected by a history of comorbid allergic diseases. The severity banding for POEM scores on the web-based survey was as follows: clear/almost clear = 0, mild = 1–8, moderate = 9–21, and severe/very severe = 22–28, which was comparable to previous banding. These results suggest that POEM is useful for determining AD severity, even in web-based surveys. Patients with POEM scores above 9 points may be grouped into moderate, severe, and very severe AD.

Significance

The Patient-Oriented Eczema Measure (POEM) is a self-assessed, repeatable measurement tool for measuring atopic dermatitis severity. A web-based questionnaire survey was conducted with POEM in 329 patients with atopic dermatitis. POEM scores were not affected by a history of comorbid allergic diseases including asthma, pollen rhinitis, allergic conjunctivitis, and food allergy. POEM was shown to be a specific measurement tool for atopic dermatitis irrespective of allergic comorbidities. POEM is useful for determining atopic dermatitis severity, not only in clinical settings, but also in a web-based survey. Patients with POEM scores > 9 points may be grouped into moderate to very severe atopic dermatitis.

Supplementary content

Comments

Not logged in! You need to login/create an account to comment on articles. Click here to login/create an account.